Page last updated: 2024-09-03

s-propylcysteine and Alzheimer Disease

s-propylcysteine has been researched along with Alzheimer Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, MW; Lin, CY; Mong, MC; Tsai, SJ; Yin, MC1
Chiu, CP; Tsai, SJ; Yang, HT; Yin, MC1

Other Studies

2 other study(ies) available for s-propylcysteine and Alzheimer Disease

ArticleYear
s-Ethyl cysteine and s-propyl cysteine alleviate beta-amyloid induced cytotoxicity in nerve growth factor differentiated PC12 cells.
    Journal of agricultural and food chemistry, 2010, Jun-09, Volume: 58, Issue:11

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Differentiation; Cell Survival; Cysteine; DNA Fragmentation; Humans; Membrane Potential, Mitochondrial; Nerve Growth Factor; Neurons; Neuroprotective Agents; PC12 Cells; Rats

2010
s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose.
    Journal of agricultural and food chemistry, 2011, Jun-08, Volume: 59, Issue:11

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cysteine; Disease Models, Animal; Galactose; Glycosylation; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress

2011